Literature DB >> 35433179

The Role of the Transorbital Superior Eyelid Approach in the Management of Selected Spheno-orbital Meningiomas: In-Depth Analysis of Indications, Technique, and Outcomes from the Study of a Cohort of 35 Patients.

Davide Locatelli1,2, Francesco Restelli1, Tommaso Alfiero1, Alberto Campione1, Fabio Pozzi1, Sergio Balbi1,2, Alberto Arosio3, Paolo Castelnuovo2,3.   

Abstract

Objective  Primary goal in spheno-orbital meningioma (SOM) surgery still remains complete resection. Nevertheless, given their highly infiltrative nature, a growing body of literature suggests to shift toward function-sparing surgeries. We here present our experience in the management of SOMs through the endoscopic superior eyelid approach (SEA). Methods  Surgical database from our multidisciplinary work group was retrospectively reviewed to identify patients treated for SOMs in the last 10 years by our senior authors, analyzing and correlating clinical, radiological, and outcome variables among the different approaches used. Results  There were 35 patients (mean age of 57.3 ± 12.86 years), with a mean follow-up of 31.5 months (range: 6-84 months). The most common preoperative complaint was proptosis (62.9%) followed by diplopia and visual deficit. Greater and lesser sphenoid wings were the areas mainly involved by the pathology (91.4% and 88.6%, respectively), whereas orbital invasion was evidenced in one-third of cases. Patients were operated on through craniotomic (48.6%), endoscopic superior eyelid (37.1%), and combined cranioendoscopic (14.3%) approaches. Simpson grades 0 to II were accomplished in 46.2% of SEA and 76.5% of craniotomies. All patients with a preoperative visual deficit improved in the postoperative period, independently from the approach used. On patients who underwent endoscopic SEA, there was improved their short-/long-term postoperative Karnofsky Performance Status. Conclusions  Endoscopic SEA is a safe and effective alternative to transcranial approaches in very selected cases of SOMs, where the planned primary objective was to obtain a maximally safe resection, aimed at symptom relief, rather than a gross total resection at any cost. Thieme. All rights reserved.

Entities:  

Keywords:  meningiomas; spheno-orbital meningioma; superior eyelid; transorbital approach

Year:  2020        PMID: 35433179      PMCID: PMC9010142          DOI: 10.1055/s-0040-1718914

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  33 in total

1.  Importance of the anatomic features of the lacrimal artery for orbital approaches.

Authors:  Senem Erdogmus; Figen Govsa
Journal:  J Craniofac Surg       Date:  2005-11       Impact factor: 1.046

2.  Endoscopic transorbital route to the cavernous sinus through the meningo-orbital band: a descriptive anatomical study.

Authors:  Iacopo Dallan; Alberto Di Somma; Alberto Prats-Galino; Domenico Solari; Isam Alobid; Mario Turri-Zanoni; Giacomo Fiacchini; Paolo Castelnuovo; Giuseppe Catapano; Matteo de Notaris
Journal:  J Neurosurg       Date:  2016-11-18       Impact factor: 5.115

3.  Combined Multiportal Endoscopic Endonasal and Transcranial Approach for Recurrent Tuberculum Sellae Meningioma: Operative Video.

Authors:  Francesco Restelli; Antonio Tabano; Fabio Pozzi; Paolo Castelnuovo; Davide Locatelli
Journal:  World Neurosurg       Date:  2019-04-09       Impact factor: 2.104

4.  Natural history of spheno-orbital meningiomas.

Authors:  Peerooz Saeed; Wouter R van Furth; Michael Tanck; Fabio Kooremans; Nicole Freling; Geert I Streekstra; Noortje I Regensburg; Jan Willem Berkelbach van der Sprenkel; Saskia M Peerdeman; Jakobus J van Overbeeke; Maarten P Mourits
Journal:  Acta Neurochir (Wien)       Date:  2010-12-01       Impact factor: 2.216

5.  Spheno-Orbital Meningiomas: A 16-Year Surgical Experience.

Authors:  Jacob L Freeman; Monica S Davern; Soliman Oushy; Stefan Sillau; D Ryan Ormond; A Samy Youssef; Kevin O Lillehei
Journal:  World Neurosurg       Date:  2016-12-23       Impact factor: 2.104

6.  Spheno-Orbital Meningiomas: When the Endoscopic Approach Is Better.

Authors:  Stefano Peron; Andrea Cividini; Laura Santi; Nicola Galante; Paolo Castelnuovo; Davide Locatelli
Journal:  Acta Neurochir Suppl       Date:  2017

7.  Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases.

Authors:  João Paulo Almeida; Sacit B Omay; Sathwik R Shetty; Yu-Ning Chen; Armando S Ruiz-Treviño; Buqing Liang; Vijay K Anand; Benjamin Levine; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2017-09-01       Impact factor: 5.115

8.  En plaque sphenoid wing meningiomas: recurrence factors and surgical strategy in a series of 71 patients.

Authors:  Giuseppe Mirone; Salvatore Chibbaro; Luigi Schiabello; Serena Tola; Bernard George
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

9.  Hyperostosing meningiomas of the sphenoid ridge--clinical features, surgical therapy, and long-term observations: review of 49 cases.

Authors:  A Pompili; P J Derome; A Visot; G Guiot
Journal:  Surg Neurol       Date:  1982-06

10.  Transorbital neuroendoscopic surgery for the treatment of skull base lesions.

Authors:  Rohan Ramakrishna; Louis J Kim; Randall A Bly; Kris Moe; Manuel Ferreira
Journal:  J Clin Neurosci       Date:  2015-11-10       Impact factor: 1.961

View more
  2 in total

1.  Endoscopic-assisted transorbital surgery: Where do we stand on the scott's parabola? personal considerations after a 10-year experience.

Authors:  Iacopo Dallan; Lodovica Cristofani-Mencacci; Giacomo Fiacchini; Mario Turri-Zanoni; Wouter van Furth; Matteo de Notaris; Miriana Picariello; Enrico Alexandre; Christos Georgalas; Luca Bruschini
Journal:  Front Oncol       Date:  2022-07-15       Impact factor: 5.738

2.  Endoscopic transorbital avenue to the skull base: Four-step conceptual analysis of the anatomic journey.

Authors:  Giulia Guizzardi; Alberto Di Somma; Matteo de Notaris; Francesco Corrivetti; Juan Carlos Sánchez; Isam Alobid; Abel Ferres; Pedro Roldan; Luis Reyes; Joaquim Enseñat; Alberto Prats-Galino
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.